-
regularly interspaced short palindromic repeats (CRISPR)-based gene editing therapies to transform lives of people with severe diseases. In fact, Intellia's co-founder Jennifer Doudna along with Emmanuelle
-
technologies such as combined single-cell ATAC and RNA multiomics, pooled CRISPR screening, and spatial transcriptomics. · Develop, apply, document, and maintain computational tools, both for own use and
Enter an email to receive alerts for crispr "https:" positions